T. Rowe Price Associates’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-598,200	Closed	-$195M	–	3072
2024 Q1	$195M	Sell	598,200 -186,769	-24%	-$45.9M	0.02%	424
2023 Q4	$150M	Sell	784,969 -452,772	-37%	-$85.6M	0.02%	469
2023 Q3	$246M	Buy	1,237,741 +146,691	+13%	+$34.7M	0.04%	351
2023 Q2	$311M	Sell	1,091,050 -303,717	-22%	-$84.3M	0.04%	319
2023 Q1	$302M	Buy	1,394,767 +382,374	+38%	+$74.5M	0.05%	313
2022 Q4	$208M	Sell	1,012,393 -784,628	-44%	-$198M	0.03%	372
2022 Q3	$500M	Sell	1,797,021 -1,417,657	-44%	-$361M	0.08%	225
2022 Q2	$615M	Buy	3,214,678 +627,712	+24%	+$111M	0.08%	248
2022 Q1	$536M	Sell	2,586,966 -490,286	-16%	-$80.8M	0.05%	317
2021 Q4	$549M	Sell	3,077,252 -142,722	-4%	-$28.1M	0.05%	336
2021 Q3	$663M	Sell	3,219,974 -76,720	-2%	-$15.1M	0.06%	300
2021 Q2	$625M	Sell	3,296,694 -642,323	-16%	-$105M	0.06%	306
2021 Q1	$513M	Buy	3,939,017 +1,458,245	+59%	+$175M	0.05%	329
2020 Q4	$257M	Buy	2,480,772 +150,031	+6%	+$13M	0.03%	459
2020 Q3	$177M	Sell	2,330,741 -243,105	-9%	-$13.8M	0.02%	512
2020 Q2	$122M	Sell	2,573,846 -91,127	-3%	-$3.75M	0.02%	581
2020 Q1	$88.4M	Sell	2,664,973 -1,365,237	-34%	-$54.2M	0.01%	606
2019 Q4	$177M	Buy	4,030,210 +418,013	+12%	+$15.4M	0.02%	507
2019 Q3	$108M	Buy	3,612,197 +1,554,422	+76%	+$66M	0.02%	610
2019 Q2	$114M	Buy	2,057,775 +162,999	+9%	+$7.92M	0.02%	611
2019 Q1	$61.4M	Buy	+1,894,776	New	+$62.9M	0.01%	793

Other funds holding SWAV